ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - SPECTRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$41
-100.0%
42,193
-35.6%
0.00%
-100.0%
Q1 2018$1,054,000
+175.2%
65,528
+140.9%
0.00%
+100.0%
Q3 2017$383,00027,2000.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders